Liposome based delivery systems in pancreatic cancer treatment: from bench to bedside.
about
Current status and progress of pancreatic cancer in ChinapH-triggered echogenicity and contents release from liposomes.Liposomal inhibition of acrolein-induced injury in rat cultured urothelial cells.Co-opting biology to deliver drugsIn-vitro and in-vivo evaluation of austocystin D liposomes.Docetaxel-loaded liposomes: preparation, pH sensitivity, pharmacokinetics, and tissue distribution.Nanotechnology and Pediatric Cancer: Prevention, Diagnosis and TreatmentGemcitabine-loaded albumin nanospheres (GEM-ANPs) inhibit PANC-1 cells in vitro and in vivo.Experimental Study of Magnetic Multi-Walled Carbon Nanotube-Doxorubicin Conjugate in a Lymph Node Metastatic Model of Breast CancerGemcitabine-loaded liposomes: rationale, potentialities and future perspectives.Optimizing efficacy of mucosal vaccines.Functional liposomes in the cancer-targeted drug delivery.Which one performs better for targeted lung cancer combination therapy: pre- or post-bombesin-decorated nanostructured lipid carriers?Exosomal formulation of anthocyanidins against multiple cancer types.Fusogenic pH sensitive liposomal formulation for rapamycin: improvement of antiproliferative effect.Efficacy and safety of liposomal clarithromycin and its effect on Pseudomonas aeruginosa virulence factors.Process optimization for the preparation of oligomycin-loaded folate-conjugated chitosan nanoparticles as a tumor-targeted drug delivery system using a two-level factorial design method.Disruption of mitochondrial complexes in cancer stem cells through nano-based drug delivery: a promising mitochondrial medicine.Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy.Cholesterol derivative-based liposomes for gemcitabine delivery: preparation, in vitro, and in vivo characterization.Nanomaterials for the Local and Targeted Delivery of Osteoarthritis Drugs
P2860
Q26799739-82886BE8-EBE1-4588-B02C-07F04FFBAD82Q30402045-2947D21B-E047-4DB5-A96B-474618867AE5Q34254303-94838FB5-B46B-4B66-A006-DD3033144CB3Q34424045-BD767F9B-9EBF-4B83-9DD6-3F060C17A693Q34565531-5BF80556-9068-41BC-9E42-3E96A127D95EQ36461825-AC04D0E1-226B-493D-AD4D-D3FF4B47C330Q36654099-60482CBC-F28C-41A5-9ADB-ED7AB9A8B1DCQ36847048-C7328551-D235-4766-9012-34873C884C49Q37097973-8ACA8E56-3A39-4D06-AE65-93D1322CE8F4Q38058785-9F4D68B2-A0E1-4DC4-965E-07E232D981F1Q38059754-006F15FA-5CB7-469A-80AC-070E5051CA26Q38396298-D9AE2583-1592-46C4-9213-AF3A958D1B1AQ38828904-A288DADB-6107-4A8A-BA2D-6F593BF3EC41Q38959552-FF7B2E7E-BBBE-41A3-BF1D-A9042529C81FQ38985738-20C6E960-500A-4701-8915-8D6E7D930BF7Q39172960-6804EE68-6437-4625-AF3A-B3049B3F720DQ39661223-A6206A0F-C048-415D-B346-6E79F8CE56F7Q46233879-64C0CA12-EFCF-4AE7-A745-93E23B22D766Q47150956-7AC5F00E-C445-4D53-BFE1-F2D03DCC9DDEQ50515897-4D1D53E7-EB63-43C9-B849-C6811D16D316Q58910462-2C56FFB7-F996-4F81-B7F5-D3DA612971EA
P2860
Liposome based delivery systems in pancreatic cancer treatment: from bench to bedside.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Liposome based delivery systems in pancreatic cancer treatment: from bench to bedside.
@en
Liposome based delivery systems in pancreatic cancer treatment: from bench to bedside.
@nl
type
label
Liposome based delivery systems in pancreatic cancer treatment: from bench to bedside.
@en
Liposome based delivery systems in pancreatic cancer treatment: from bench to bedside.
@nl
prefLabel
Liposome based delivery systems in pancreatic cancer treatment: from bench to bedside.
@en
Liposome based delivery systems in pancreatic cancer treatment: from bench to bedside.
@nl
P2093
P1476
Liposome based delivery systems in pancreatic cancer treatment: from bench to bedside.
@en
P2093
Deliang Fu
Quanxing Ni
Yongjian Jiang
P304
P356
10.1016/J.CTRV.2011.01.006
P577
2011-02-16T00:00:00Z